Search for: "Cephalon Inc."
Results 61 - 80
of 151
Sort by Relevance
|
Sort by Date
18 Jul 2011, 5:16 pm
(“Cephalon”) on March 15, 2011 challenging FDA’s January 7, 2011 approval of Watson Laboratories, Inc. [read post]
27 Jun 2011, 2:18 am
Court of Appeal (Criminal Division) Manchester Police, R (On the Application Of) v Hookway & Anor [2011] EWHC 1578 (Admin) (19 May 2011) Attorney General v Fraill & Anor [2011] EWCA Crim 1570 (16 June 2011) Court of Appeal (Civil Division) Zinda v Bank of Scotland Plc [2011] EWCA Civ 706 (23 June 2011) High Court (Chancery Division) Chemistree Homecare Ltd & Ors v Roche Products Ltd [2011] EWHC 1579 (Ch) (16 June 2011) Cowderoy v Cranfield [2011] EWHC 1616 (Ch) (24 June 2011) High… [read post]
6 May 2011, 4:54 pm
In Cephalon, Inc. v. [read post]
6 May 2011, 3:00 am
Fox and Symons led Kirkland's team advising Teva Pharmaceuticals on its $6.8 billion acquisition of Cephalon, Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
31 Mar 2011, 8:43 am
Cephalon Inc. v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
17 Mar 2011, 7:47 am
" Cephalon Inc., et. al. v. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
22 Nov 2010, 2:09 am
Court of Appeal (Criminal Division) Kuku, R. v [2010] EWCA Crim 2533 (13 October 2010) Court of Appeal (Civil Division) KCI Licensing Inc & Ors v Smith & Nephew Plc & Ors [2010] EWCA Civ 1260 (18 November 2010) Starglade Properties Ltd v Nash [2010] EWCA Civ 1314 (19 November 2010) Tilson v Alstom Transport [2010] EWCA Civ 1308 (19 November 2010) Ingram v Williams [2010] EWCA Civ 1313 (19 November 2010) High Court (Queen’s Bench Division) JIH v News Group Newspapers… [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
23 Aug 2010, 9:56 pm
Cephalon, Inc. et al. v. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
12 Aug 2010, 9:18 pm
By James DeGiulio -- Cephalon and Mylan Pharmaceuticals Agree to Drop Two Patents from Nuvigil Patent Suit Cephalon Inc. and Mylan Pharmaceuticals Inc. have agreed to drop two of the three patents originally involved in their infringement suit over the narcolepsy drug Nuvigil. [read post]
7 Jun 2010, 5:00 am
Clinical research sites across the world are working with biopharmaceutical company Cephalon, Inc., as part of the study to test the effectiveness and safety of an investigational treatment for people with excessive sleepiness caused by a concussion or head injury. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
25 Apr 2010, 5:52 pm
Cephalon, Inc. [read post]
